BioSpace News Archive

Business

Arrogance, Ambition and Sloppiness: More Details Behind the CRISPR Babies Story

In an in-depth investigation, STAT reported on behind-the-scenes activities at the Second International Summit on Human Genome Editing at the University of Hong Kong, where He made his announcement.

December 17, 2018
·
4 min read
·
Mark Terry
Deals

As GSK Bets on Tesaro’s Zejula, Clovis Stock Takes a Hit

Shares of Clovis Oncology fell more than 4 percent Friday after additional details surrounding GlaxoSmithKline’s $5.1 billion acquisition of Waltham, Mass.-based Tesaro Inc. was brought to life in a filing with the U.S. Securities and Exchange Commission.

December 17, 2018
·
2 min read
·
Alex Keown
Business

Commemorating a quarter century as a continuing partner of St. Jude Children’s Research Hospital®, National Beverage Corp. (NASDAQ:FIZZ), implores all to join its mission to provide miracles for children stricken with life-threatening illnesses.

Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today announces that it has entered into an exclusive target discovery partnership with C4X Discovery Holdings plc (AIM: C4XD)(“C4XD”), a pioneering drug discovery company.

December 17, 2018
·
6 min read
Ministry of Health and Prevention announces Al Qassimi Hospital in Sharjah awarded international accreditation by JCI

UAE remains number 1 globally with highest number of accredited health facilities

December 17, 2018
·
4 min read
Flu vaccinations can work as effectively in the active healthy elderly compared to the young

Clinical trial results also suggest that immune responses to flu vaccinations in independent elderly individuals are not affected by their levels of frailty

December 17, 2018
·
7 min read
Pharm Country

Research Article Cites Cleanascite™ To Study Neurodegenerative Diseases

Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid clearance sample preparation technology for studying cell response factors associated with cells of the central nervous system.

December 17, 2018
·
3 min read
Pharm Country

Nature Article Highlights AlbuVoid™ in Autophagy and Cancer Study

Biotech Support Group reports on a new research report which highlights the simplicity and efficiency of their Albumin depletion sample preparation technology as an enrichment step for mouse serum LC-MS proteomic analysis.

December 17, 2018
·
2 min read
FDA

Celltrion and Teva Snag Second Biosimilar Approval of a Genentech Drug

The U.S. Food and Drug Administration approved another biosimilar. On Friday, the regulatory agency approved Herzuma, a biosimilar to Genentech’s Herceptin developed by South Korea-based Celltrion, Inc. and Israel-based Teva Pharmaceuticals.

December 17, 2018
·
2 min read
·
Alex Keown
Business

Seer Launches to Develop Protein-Based Liquid Biopsies

Yet another company has launched to develop liquid biopsies. Founded and headed by Omid Farokhzad, formerly a professor at Brigham and Women’s Hospital, Seer is based in San Francisco.

December 17, 2018
·
2 min read
·
Mark Terry
Drug Development

Eli Lilly’s Taltz Stands up to Humira in Psoriatic Arthritis Patients

At 24 weeks, the study met its primary endpoint. Lilly’s Taltz demonstrated superiority against AbbVie’s Humira, the best-selling drug in the world, in improving the signs and symptoms of active PsA.

December 17, 2018
·
2 min read
·
Alex Keown